FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Conventional markers used for diagnosing and managing diabetes have recently come to question. This blog addresses some of ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

This triggers the pancreas to make and release more glucagon ... Read more about how insulin and glucagon regulate blood sugar. Most research has involved animals rather than humans.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Yes, weightloss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s ...

Signs an Amended & Restated License Agreement for Multiple Technologies for Gene Therapy for Type 1 and Type 2 Diabetes Forms a Wholl ...

A 32-year-old man developed gastroparesis after taking tirzepatide for weight loss, which isn't approved in India. Doctors ...

It is the world's first tubeless insulin delivery system ... closest to a complete artificial pancreas, however, are those that also administer glucagon. Beta Bionics' iLet has shown promise ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...